Stratasys Ltd. (NASDAQ:SSYS) to Post Q1 2024 Earnings of ($0.15) Per Share, Zacks Research Forecasts

Stratasys Ltd. (NASDAQ:SSYS - Free Report) - Stock analysts at Zacks Research cut their Q1 2024 earnings per share (EPS) estimates for shares of Stratasys in a research report issued to clients and investors on Tuesday, March 26th. Zacks Research analyst R. Department now forecasts that the technology company will earn ($0.15) per share for the quarter, down from their previous forecast of ($0.04). The consensus estimate for Stratasys' current full-year earnings is ($0.30) per share. Zacks Research also issued estimates for Stratasys' Q2 2024 earnings at ($0.09) EPS, Q3 2024 earnings at ($0.04) EPS, Q1 2025 earnings at $0.12 EPS, Q2 2025 earnings at $0.14 EPS, Q3 2025 earnings at $0.11 EPS, Q4 2025 earnings at $0.15 EPS and FY2025 earnings at $0.50 EPS.

Other equities research analysts have also issued reports about the company. Needham & Company LLC reiterated a "buy" rating and issued a $16.00 price objective on shares of Stratasys in a research report on Tuesday, December 26th. Cantor Fitzgerald initiated coverage on Stratasys in a research report on Tuesday, February 13th. They issued an "overweight" rating and a $24.00 price objective on the stock. Finally, StockNews.com initiated coverage on Stratasys in a research report on Tuesday. They set a "buy" rating on the stock.

Stratasys Stock Performance

SSYS stock traded down $0.22 during trading on Friday, hitting $11.62. 170,294 shares of the company traded hands, compared to its average volume of 342,049. The firm has a market capitalization of $809.45 million, a PE ratio of -6.49 and a beta of 1.30. Stratasys has a 1 year low of $9.95 and a 1 year high of $21.72. The company has a 50-day moving average of $12.59 and a 200-day moving average of $12.30.

Stratasys (NASDAQ:SSYS - Get Free Report) last issued its earnings results on Thursday, March 7th. The technology company reported $0.02 earnings per share for the quarter, meeting the consensus estimate of $0.02. The company had revenue of $156.34 million during the quarter, compared to analysts' expectations of $153.96 million. Stratasys had a negative return on equity of 2.28% and a negative net margin of 19.61%. Stratasys's quarterly revenue was down 1.8% compared to the same quarter last year. During the same period in the prior year, the business posted ($0.03) EPS.

Institutional Investors Weigh In On Stratasys

Several hedge funds have recently made changes to their positions in SSYS. RIA Advisory Group LLC bought a new stake in shares of Stratasys during the fourth quarter valued at approximately $33,000. CWM LLC raised its stake in Stratasys by 2,633.3% during the third quarter. CWM LLC now owns 3,280 shares of the technology company's stock valued at $45,000 after buying an additional 3,160 shares during the last quarter. FMR LLC raised its stake in Stratasys by 12,707.1% during the third quarter. FMR LLC now owns 3,586 shares of the technology company's stock valued at $49,000 after buying an additional 3,558 shares during the last quarter. Captrust Financial Advisors raised its stake in Stratasys by 315.6% during the second quarter. Captrust Financial Advisors now owns 3,071 shares of the technology company's stock valued at $58,000 after buying an additional 2,332 shares during the last quarter. Finally, Tower Research Capital LLC TRC raised its stake in Stratasys by 560.4% during the third quarter. Tower Research Capital LLC TRC now owns 4,471 shares of the technology company's stock valued at $61,000 after buying an additional 3,794 shares during the last quarter. 75.77% of the stock is currently owned by institutional investors.

About Stratasys

Stratasys Ltd. provides connected polymer-based 3D printing solutions. It offers range of 3D printing systems, which includes polyjet printer, Fused Deposition Modeling (FDM) printers, stereolithography printing systems, origin P3 printers, and SAF printer for manufacturing, tooling and rapid prototyping, and various vertical markets, such as automotive, aerospace, consumer products and healthcare.